Sobrevida das mulheres idosas com diagnóstico de câncer de mama em hospital de referência no Espírito Santo

• Ano de defesa: 2017
• Autor(a) principal: Moraes, Samantha Helena
• Tipo de documento: Dissertação
• Tipo de acesso: Acesso aberto
• Idioma: por
• Instituição de defesa: Universidade Federal do Espírito Santo; BR; Mestrado em Saúde Coletiva; Centro de Ciências da Saúde; UFES; Programa de Pós-Graduação em Saúde Coletiva
• Palavras-chave em Português: Breast neoplasms; Mortality; Survival analysis; Rehabilitation; Women's health; Neoplasias da mama; Mortalidade; Análise de sobrevida; Saúde da mulher; Mamas - Câncer; Reabilitação; Mulheres - Saúde; Câncer - Pacientes - Espírito Santo (Estado); Saúde Coletiva; 614
• Link de acesso: http://repositorio.ufes.br/handle/10/10114

INTRODUCTION: Cancer represents a serious and continuing public health problem, being an important cause of morbidity and mortality, especially breast cancer in the elderly woman. Currently, about 30% to 50% of breast cancer cases are found in the elderly woman. Objetives: To compare the lethality and survival of the cases of elderly women with breast cancer attended at the Hospital Santa Rita de Cassia, enrolled and not enrolled in the PREMMA, in the period of 10 years Method: Two studies were carried out: the first is a retrospective cohort study and the second refers to a survival study using secondary data. The sample consisted of 969 cases of elderly women diagnosed with breast cancer at the Hospital Santa Rita de Cássia. To identify the outcome, data from the Mortality Information System was used. Results: There was a predominance of women of non-white race / color, the age group from 60 to 69 years old, low level of education, married: married, with the origin of referral to the HSRC by SUS and early staging. With respect to tumor markers, it is noted that in most women the hormonal receptors showed positivity and the markers P53 and Erb-B2 were negative. Death was present in 278 women and the mean survival time in 130.8 months for the 10-year period was estimated. After the multivariate analysis, a higher risk of low survival is evident in women with pathways of SUS origin, late staging, presence of metastasis and estrogen marker positivity. Conclusão: In this study, the outcome was determined by the increase in age, low level of schooling, late diagnosis, tumor markers and SUS diagnosis and referral. In face of the picture, it is necessary to better approach those that are more susceptible to disease, allowing better access to health services and treatment.